Insufficient scRNA-seq data for expression of CYP1A2 at single-cell level.
Insufficient scRNA-seq data for expression of CYP1A2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 242.44 | 649 / 653 | 62% | 2.22 | 374 / 605 |
liver | 99% | 11557.42 | 224 / 226 | 55% | 70.60 | 223 / 406 |
lung | 53% | 43.17 | 306 / 578 | 2% | 0.17 | 18 / 1155 |
skin | 34% | 51.39 | 622 / 1809 | 0% | 0.03 | 1 / 472 |
kidney | 24% | 9.03 | 21 / 89 | 6% | 0.84 | 52 / 901 |
ovary | 0% | 0 | 0 / 180 | 24% | 1.30 | 102 / 430 |
adipose | 17% | 7.65 | 199 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 14% | 11.64 | 126 / 929 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 10% | 17.30 | 48 / 504 |
prostate | 7% | 2.49 | 18 / 245 | 1% | 0.02 | 5 / 502 |
breast | 8% | 3.12 | 36 / 459 | 0% | 0.00 | 1 / 1118 |
adrenal gland | 5% | 1.81 | 13 / 258 | 1% | 0.01 | 2 / 230 |
esophagus | 4% | 1.65 | 55 / 1445 | 2% | 0.04 | 3 / 183 |
uterus | 1% | 0.24 | 2 / 170 | 2% | 0.26 | 10 / 459 |
blood vessel | 3% | 1.48 | 44 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 1% | 0.24 | 4 / 328 | 1% | 0.10 | 2 / 178 |
stomach | 1% | 0.35 | 3 / 359 | 1% | 0.02 | 4 / 286 |
heart | 2% | 0.91 | 15 / 861 | 0% | 0 | 0 / 0 |
intestine | 1% | 0.32 | 10 / 966 | 0% | 0.14 | 2 / 527 |
spleen | 1% | 9.37 | 3 / 241 | 0% | 0 | 0 / 0 |
brain | 0% | 0.12 | 11 / 2642 | 0% | 0 | 0 / 705 |
muscle | 0% | 0.02 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009403 | Biological process | toxin biosynthetic process |
GO_0010468 | Biological process | regulation of gene expression |
GO_0030324 | Biological process | lung development |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0009791 | Biological process | post-embryonic development |
GO_0032259 | Biological process | methylation |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0071276 | Biological process | cellular response to cadmium ion |
GO_0045333 | Biological process | cellular respiration |
GO_0016098 | Biological process | monoterpenoid metabolic process |
GO_0006778 | Biological process | porphyrin-containing compound metabolic process |
GO_0097267 | Biological process | omega-hydroxylase P450 pathway |
GO_0009820 | Biological process | alkaloid metabolic process |
GO_0019373 | Biological process | epoxygenase P450 pathway |
GO_0042178 | Biological process | xenobiotic catabolic process |
GO_0046222 | Biological process | aflatoxin metabolic process |
GO_0050665 | Biological process | hydrogen peroxide biosynthetic process |
GO_0042572 | Biological process | retinol metabolic process |
GO_0008210 | Biological process | estrogen metabolic process |
GO_0042759 | Biological process | long-chain fatty acid biosynthetic process |
GO_0006706 | Biological process | steroid catabolic process |
GO_0070989 | Biological process | oxidative demethylation |
GO_0032787 | Biological process | monocarboxylic acid metabolic process |
GO_0018894 | Biological process | dibenzo-p-dioxin metabolic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0019899 | Molecular function | enzyme binding |
GO_0032451 | Molecular function | demethylase activity |
GO_0070330 | Molecular function | aromatase activity |
GO_0009055 | Molecular function | electron transfer activity |
GO_0016712 | Molecular function | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
GO_0101020 | Molecular function | estrogen 16-alpha-hydroxylase activity |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
GO_0034875 | Molecular function | caffeine oxidase activity |
GO_0106256 | Molecular function | hydroperoxy icosatetraenoate dehydratase activity |
GO_0005515 | Molecular function | protein binding |
GO_0101021 | Molecular function | estrogen 2-hydroxylase activity |
Gene name | CYP1A2 |
Protein name | Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) |
Synonyms | |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) . Catalyzes the hydroxylation of carbon-hydrogen bonds . Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2 . Metabolizes cholesterol toward 25-hydroxycholesterol, a physiological regulator of cellular cholesterol homeostasis . May act as a major enzyme for all-trans retinoic acid biosynthesis in the liver. Catalyzes two successive oxidative transformation of all-trans retinol to all-trans retinal and then to the active form all-trans retinoic acid . Primarily catalyzes stereoselective epoxidation of the last double bond of polyunsaturated fatty acids (PUFA), displaying a strong preference for the (R,S) stereoisomer . Catalyzes bisallylic hydroxylation and omega-1 hydroxylation of PUFA . May also participate in eicosanoids metabolism by converting hydroperoxide species into oxo metabolites (lipoxygenase-like reaction, NADPH-independent) . Plays a role in the oxidative metabolism of xenobiotics. Catalyzes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin . Metabolizes caffeine via N3-demethylation (Probable). . |
Accessions | ENST00000343932.5 P05177 |